BAT-BMS app was allegedly used to remotely disable certain e-rickshaws, why some Bluetooth-enabled battery systems became ...

A recent survey suggests that using apps and artificial intelligence for health advice may be linked to vaccine distrust.

Add Yahoo as a preferred source to see more of our stories on Google. By using genetic code gathered from global virus surveillance programs, the researchers have pieced together a "super-antigen" ...

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against ...

Bluetooth dual device connectivity, aka "multipoint," isn't an official feature or spec. It's an application of Bluetooth technologies, and each manufacturer wields it differently. Further migration ...

An experimental vaccine from Moderna and Merck shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results. Subscribe to read this story ad-free Get ...

More and more routine vaccines are being linked to lower risks of dementia. Shots against seasonal flu, RSV, tetanus, diphtheria, and pertussis (Tdap), pneumococcal infections, hepatitis A and B, and ...

Respiratory syncytial virus (RSV) is a familiar seasonal illness, but the tools to prevent it are new. Canada has recently approved vaccines for older adults and pregnant people, along with a ...

Since 2015, trust in vaccine safety has declined in most countries surveyed by the Vaccine Confidence Project, a research group at the London School of Hygiene & Tropical Medicine that monitors global ...

Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent Lyme disease last month, two questions have loomed large: Will the vaccine ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.